Peculiarities of BRCA1/2 testing in patients with advanced HER2-negative breast cancer in the Russian Federation (results of a survey of Russian oncologists)
Автор: Frolova Mona A., Stenina Marina B.
Журнал: Злокачественные опухоли @malignanttumors
Рубрика: Вопросы онкохирургии
Статья в выпуске: 2 т.11, 2021 года.
Бесплатный доступ
Hereditary BRCA1 / 2 mutations affect the strategy of surgical treatment in early cancer and systemic treatment in advanced HER2-negative breast cancer. The article presents the results of a survey of Russian oncologists on various aspects of genetic testing for hereditary BRCA1 / 2 mutations in real-world clinical practice. Indications for testing, testing methods, and funding sources were discussed.
Breast cancer, hereditary brca1/ 2 mutations, genetic testing
Короткий адрес: https://sciup.org/140290742
IDR: 140290742 | DOI: 10.18027/2224-5057-2021-11-2-38-44